As it is possible that other members of the Cell Adhesion Molecule (CAM) family can compensate for the role of CD166 in murine prostate cancer development, we cannot conclude that CD166 has no in vivo function on prostate cancer initiation. The gene discussed is ALCAM; the disease is Familial prostate cancer.